symptomatology and outcomes of women with ......symptomatology and outcomes of women with...

1
Symptomatology and Outcomes of Women with Hyperemesis Gravidarum as Reported in a Large Registry Lisa M. Korst, Borzouyeh Poursharif, Kimber W. MacGibbon, Marlena S. Fejzo, Roberto Romero, and T. Murphy Goodwin 1 University of Southern California, Obstetrics and Gynecology, Los Angeles, California, 2 Hyperemesis Education and Research Foundation, Leesburg, Virginia, 3 NICHD, NIH, DHHS, Perinatology Research Branch, Detroit, Michigan Objective Our objective is to report the breadth and severity of their symptomatology, and their maternal and fetal outcomes. This is the first report of a large number of affected women from an HG registry. Introduction Hyperemesis gravidarum (HG) is a severe form of nausea and vomiting of pregnancy (NVP), occurring in 1-2% of pregnant women. Our understanding of the spectrum of symptoms and outcomes derives largely from small series of HG patients, giving an incomplete view of this condition. Methods The nonprofit Hyperemesis Education and Research (HER) Foundation administered an on-line survey from 2003-2005, questioning women regarding their symptomatology, and maternal and fetal outcomes. A control population was recruited largely from on-line parenting groups. HG was defined as significant weight loss and debility secondary to nausea and vomiting during pregnancy, typically requiring medications and/or IV fluids for treatment. Women with at least one gestation of at least 27 weeks duration, were the subject of this analysis, and data from early pregnancies that were lost were not included. As women reported on multiple pregnancies, data regarding the specific characteristics and outcomes of pregnancies were aggregated at the level of the woman. Thus, if the characteristic of interest was found in any one of her pregnancies, that characteristic was noted, and the proportion of women who had at least one pregnancy with that characteristic was reported. Odds ratios (OR) were adjusted for the number of pregnancies > 27 weeks per woman. Results The study population included 819 cases and 541 controls. Of the 384 women with HG who reported having more than one pregnancy, 95% reported a recurrence. Women reported their most severe weight loss among all their pregnancies: o 16% lost < 5% of pre-pregnancy weight o 27% lost 5%-10% of pre-pregnancy weight o 46% lost 10-20% of pre-pregnancy weight o 10% lost > 20% of pre-pregnancy weight Weight loss > 15% (N=214, 26%) was significantly associated: During Pregnancy with: oExcess salivation oGall bladder and liver dysfunction oHematemesis oMuscle pain oRenal failure oRetinal hemorrhage In the Postpartum Period with: oLonger recovery time oGall bladder dysfunction oInsomnia oMuscle pain oNausea oPTSD Women with weight loss > 15% were nearly twice as likely as other women with HG to continue to have symptoms throughout pregnancy [63/214 (29%) vs. 117/605 (19%), OR = 1.73, 95% CI (1.20-2.47), P = 0.003]. Results (cont): Postpartum, cases were more likely than controls to report bonding difficulties and negative feelings toward the baby, and continued excess vomiting and weight management problems. Summary oHG is associated with a broader spectrum of symptoms during pregnancy than has been previously reported. oSome physical changes related to HG do not resolve with delivery. oChildren of mothers with HG are more likely to be reported as having behavioral, emotional, and learning disorders. oSevere HG, as indicated by greater weight loss, is associated with greater morbidity during pregnancy and higher persistence of HG- associated symptoms postpartum. Conclusions Prenatal care practitioners should be aware of the broad spectrum of symptoms related to HG so that they can provide appropriate interventions and support. Effects of HG persisting postpartum, and effects of HG on the offspring have not previously been reported and should be investigated further. P < 0.001 465 (86%) 57 (11%) 2 (0%) 8 (1%) 9 (2%) 656 (80%) 57 (7%) 40 (5%) 28 (3%) 38 (5%) Residence USA UK Australia Canada Other P < 0.001 442 (82%) 6 (1%) 13 (2%) 47 (9%) 33 (6%) 698 (85%) 20 (2%) 31 (4%) 16 (2%) 54 (7%) Race/Ethnicity White Black Hispanic Asian Other P < 0.001 35 + 6 35 (19-62) 32 + 5 32 (20-62) Maternal age (yrs) N = 541 N = 819 Number of subjects P values Controls Cases Patient Demographics Selected Pregnancy Characteristics among Cases and Controls 0 5 10 15 20 25 30 35 40 Hypersalivation Hematemesis Oral Bleeding Hypotension Memory Loss Muscle Pain Changed Doctor PP Digestive Problems PP Food Aversions PP PTSD Child with Behavioral Disorder Child with Emotional Disorder Child with Learning Disorder Child with Sensory Disorder Prevalence (%) Cases Controls

Upload: others

Post on 31-Mar-2020

8 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Symptomatology and Outcomes of Women with ......Symptomatology and Outcomes of Women with Hyperemesis Gravidarum as Reported in a Large Registry Lisa M. Korst, Borzouyeh Poursharif,

Symptomatology and Outcomes of Women withHyperemesis Gravidarum as Reported in a Large Registry

Lisa M. Korst, Borzouyeh Poursharif, Kimber W. MacGibbon, Marlena S. Fejzo, Roberto Romero, and T. Murphy Goodwin1University of Southern California, Obstetrics and Gynecology, Los Angeles, California,

2Hyperemesis Education and Research Foundation, Leesburg, Virginia, 3NICHD, NIH, DHHS, Perinatology Research Branch, Detroit, Michigan

Objective

Our objective is to report the breadth and severityof their symptomatology, and their maternal andfetal outcomes. This is the first report of a largenumber of affected women from an HG registry.

Introduction

Hyperemesis gravidarum (HG) is a severe formof nausea and vomiting of pregnancy (NVP),occurring in 1-2% of pregnant women. Ourunderstanding of the spectrum of symptoms andoutcomes derives largely from small series of HGpatients, giving an incomplete view of thiscondition.

Methods

The nonprofit Hyperemesis Education and Research(HER) Foundation administered an on-line surveyfrom 2003-2005, questioning women regarding theirsymptomatology, and maternal and fetal outcomes.

A control population was recruited largely from on-lineparenting groups. HG was defined as significantweight loss and debility secondary to nausea andvomiting during pregnancy, typically requiringmedications and/or IV fluids for treatment. Womenwith at least one gestation of at least 27 weeksduration, were the subject of this analysis, and datafrom early pregnancies that were lost were notincluded. As women reported on multiplepregnancies, data regarding the specificcharacteristics and outcomes of pregnancies wereaggregated at the level of the woman. Thus, if thecharacteristic of interest was found in any one of herpregnancies, that characteristic was noted, and theproportion of women who had at least one pregnancywith that characteristic was reported. Odds ratios(OR) were adjusted for the number of pregnancies >27 weeks per woman.

Results

The study population included 819 cases and 541controls. Of the 384 women with HG who reportedhaving more than one pregnancy, 95% reported arecurrence.

Women reported their most severe weight lossamong all their pregnancies:

o 16% lost < 5% of pre-pregnancy weighto 27% lost 5%-10% of pre-pregnancy weighto 46% lost 10-20% of pre-pregnancy weighto 10% lost > 20% of pre-pregnancy weight

Weight loss > 15% (N=214, 26%) was significantlyassociated:

During Pregnancy with:oExcess salivationoGall bladder and liver dysfunctionoHematemesisoMuscle painoRenal failureoRetinal hemorrhage

In the Postpartum Period with:oLonger recovery timeoGall bladder dysfunctionoInsomniaoMuscle painoNauseaoPTSD

Women with weight loss > 15% were nearly twiceas likely as other women with HG to continue tohave symptoms throughout pregnancy [63/214(29%) vs. 117/605 (19%), OR = 1.73, 95% CI(1.20-2.47), P = 0.003].

Results (cont):

Postpartum, cases were more likely than controlsto report bonding difficulties and negativefeelings toward the baby, and continued excessvomiting and weight management problems.

Summary

oHG is associated with a broader spectrum ofsymptoms during pregnancy than has beenpreviously reported.

oSome physical changes related to HG do notresolve with delivery.

oChildren of mothers with HG are more likely tobe reported as having behavioral, emotional, andlearning disorders.

oSevere HG, as indicated by greater weight loss,is associated with greater morbidity duringpregnancy and higher persistence of HG-associated symptoms postpartum.

Conclusions

Prenatal care practitioners should be aware ofthe broad spectrum of symptoms related to HGso that they can provide appropriateinterventions and support.

Effects of HG persisting postpartum, and effectsof HG on the offspring have not previously beenreported and should be investigated further.

P < 0.001

465 (86%)57 (11%)

2 (0%)8 (1%)9 (2%)

656 (80%)57 (7%)40 (5%)28 (3%)38 (5%)

ResidenceUSAUKAustraliaCanadaOther

P < 0.001

442 (82%)6 (1%)

13 (2%)47 (9%)33 (6%)

698 (85%)20 (2%)31 (4%)16 (2%)54 (7%)

Race/EthnicityWhiteBlackHispanicAsianOther

P < 0.00135 + 6

35 (19-62)32 + 5

32 (20-62)Maternal age (yrs)

N = 541N = 819Number of subjects

P valuesControlsCases

Patient Demographics

Selected Pregnancy Characteristicsamong Cases and Controls

05

10

1520

253035

40

Hyper

saliv

atio

n

Hemat

emes

is

Ora

l Bleed

ing

Hypote

nsion

Mem

oryLoss

Musc

lePai

n

Changed

Doctor

PPDig

estiv

ePro

blem

s

PPFood

Avers

ions

PPPTSD

Childwith

Behav

iora

l Disord

er

Childwith

Emotio

nalDis

order

Childwith

Learn

ing

Disord

er

Childwith

Senso

ryDis

order

Pre

va

len

ce

(%)

Cases Controls